Terumo Aortic announced enrollment of the first patient in the RapidLink pivotal trial, which will evaluate the safety and ...

PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...

The American College of Cardiology (ACC) and American Heart Association (AHA) have issued the “2026 ACC/AHA Clinical Perfo ...

Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...

Gore & Associates announced FDA approval of the Gore Viabahn Fortegra venous stent—previously known as the Gore Viafor ...

Ceribell, Inc. announced that the FDA has granted Breakthrough Device designation for its large vessel occlusion (LVO) stroke de ...

Galaxy Therapeutics announced it has completed enrollment in the SEAL IT pivotal trial evaluating the company’s saccular ...

CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...

The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery dise ...

December 3, 2025—Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeGraft Plus, which features a new 77/78-mm length. On November ...

November 19, 2025—Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair (BEVAR), expanding Bentley’s ...

November 17, 2025—Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the company by an affiliate of GTCR LLC. In May 2024, the company ...